CIP
NVO

Chartwell Investment Partners’s Novo Nordisk NVO Stock Holding History

Chartwell Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.06M Sell
25,722
-951
-4% -$127K 0.11% 243
2024
Q2 		$3.81M Sell
26,673
-255
-0.9% -$33.8K 0.13% 216
2024
Q1 		$3.46M Sell
26,928
-1,114
-4% -$133K 0.12% 232
2023
Q4 		$2.9M Sell
28,042
-220
-0.8% -$21.8K 0.1% 246
2023
Q3 		$2.57M Buy
+28,262
New +$2.49M 0.1% 248

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Chartwell Investment Partners's NVO Position: Q3 2024 in Review

Chartwell Investment Partners reduced its Novo Nordisk (NVO) stake by 3.6% in Q3 2024, selling an estimated $127K and leaving 25,722 shares worth $3.06M. The position accounts for 0.11% of the portfolio, ranked #243.

Chartwell Investment Partners first reported a position in NVO in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.81M in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Chartwell Investment Partners held 25,722 shares of Novo Nordisk worth $3.06M as of Q3 2024.
  • Chartwell Investment Partners sold 951 Novo Nordisk shares in Q3 2024, an estimated $127K.
  • Novo Nordisk made up 0.11% of Chartwell Investment Partners's portfolio in Q3 2024, its #243 holding.
  • Chartwell Investment Partners first reported a position in Novo Nordisk in Q3 2023 and has held it in 5 quarters since.
  • Chartwell Investment Partners's Novo Nordisk position peaked at $3.81M in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.